CFS model establishment procedures resulted in levels of MDA and ROS increasing strongly and SOD and GSH-Px reducing in serum, liver, and muscle (P < 0.05; Table 7). The gene discussed is SOD1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.